Showing 2771-2780 of 8826 results for "".
Physician Spotlight: Meena Singh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-meena-singh/23939/The Art of Patient Scheduling
https://practicaldermatology.com/topics/practice-management/the-art-of-patient-scheduling/23676/Is your patient scheduling system working as efficiently as possible? Put these five action items in place to ensure your practice is firing on all cylinders.Muscle Makers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/muscle-makers/23541/The newest body sculpting technologies show promise for building muscle and strength.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Your Comprehensive Guide to Energy-Based Devices
https://practicaldermatology.com/topics/practice-management/your-comprehensive-guide-to-energy-based-devices/23146/Physician Spotlight With A. Yasmine Kirkorian, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-a-yasmine-kirkorian-md/23082/More Advice for Residents; AMA Calls for More Residency Slots; Call for Submissions
https://practicaldermatology.com/youngmd-connect/resident-resource-center/more-advice-for-residents-ama-calls-for-more-residency-slots-call-for-submissions/20437/A Review of Incident to Services
https://practicaldermatology.com/topics/practice-management/a-review-of-incident-to-services/20526/In order to ensure correct billing—and reimbursements—it is important to understand incident to policies.Content Marketing for Dermatologists
https://practicaldermatology.com/topics/practice-management/content-marketing-for-dermatologists/20536/A mix of time-sensitive and evergreen content is best to optimize engagement.Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or active